Joycelyn Chun
Physician Assistant · Honolulu, HINPI 1760037089
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 327 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 19.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,492, 4.6 times the $767 reported in 2021. Among physician assistant clinicians in HI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 327 payments — averaging $34.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$2K
- AbbVie$2K
- Indivior Inc.$1K
- Novo Nordisk$1K
- Alkermes, Inc.$911
- Otsuka America Pharmaceutical, Inc.$909
- plus $3K from 20 others
What the payments were for
- Food & beverage$11,22399%
- Education$1001%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 102 | $2,210 |
| AbbVie | 46 | $1,654 |
| Indivior Inc. | 48 | $1,214 |
| Novo Nordisk | 10 | $1,065 |
| Alkermes, Inc. | 18 | $911 |
| Otsuka America Pharmaceutical, Inc. | 16 | $909 |
| Teva Pharmaceuticals USA, Inc. | 25 | $791 |
| Viiv Healthcare Company | 10 | $449 |
| Johnson & Johnson(2 entities) | 10 | $326 |
| Boehringer Ingelheim | 10 | $266 |
| Janssen Products, LP | 2 | $213 |
| Dexcom, Inc. | 4 | $181 |
| Insulet Corporation | 1 | $150 |
| Lundbeck LLC | 5 | $134 |
| Amgen | 1 | $122 |
| Amarin Pharma, Inc. | 2 | $120 |
| Intercept Pharmaceuticals, Inc. | 1 | $118 |
| Abbott | 1 | $116 |
| GSK | 3 | $74 |
| Madrigal Pharmaceuticals | 2 | $66 |
| Merck | 3 | $66 |
| EMD Serono, Inc. | 2 | $56 |
| Novartis | 2 | $49 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $26 |
| E.r. Squibb & Sons, L.L.C. | 1 | $23 |
| Bayer | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$1,878
- ABILIFY MAINTENA$545
- ABILIFY ASIMTUFII$545
- ARISTADA$473
- Ozempic$361
- RYBELSUS$360
- Vemlidy$272
- Yeztugo$260
- VRAYLAR$250
- Austedo XR$250
- PERSERIS$245
- UZEDY$238
- Mavyret$231
- INVEGA SUSTENNA$150
- Omnipod$150
- DEXCOM G7 GSS (161)$135
- DEXCOM STELO GLUCOSE BIOSENSOR$135
- DALVANCE$125
- VIVITROL$125
- Epclusa$122
How this compares
$11,323 in reported general payments places this provider in the 95th percentile of 246 physician assistant providers in Hawaii.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 26 | $25,845 |
| JardianceEmpagliflozin | 20 | $25,639 |
| OzempicSemaglutide | 13 | $14,721 |
| EliquisApixaban | 12 | $9,641 |
| Wixela InhubFluticasone Propion/Salmeterol | 11 | $1,898 |
| Atorvastatin Calcium | 76 | $602 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 36 | $557 |
| Metformin Hcl | 49 | $529 |
| Montelukast Sodium | 13 | $451 |
| Oxycodone Hcl | 16 | $430 |
| Amlodipine Besylate | 45 | $418 |
| Metoprolol Succinate | 21 | $233 |
| Simvastatin | 19 | $220 |
| Gabapentin | 14 | $216 |
| Lisinopril | 37 | $194 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $266 | $25,63920 claims |
| Novo NordiskOzempic | $1,065 | $14,72113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 246 physician assistant providers in Hawaii.
Other physician assistant in Honolulu
- Eric YukumotoHonolulu$41K
- Dorothy MauriceHonolulu$39K
- Rachel InouyeHonolulu$11K
- Timothy HowardHonolulu$10K
- Tiffany TranHonolulu$6K
- Jamie TamayoseHonolulu$5K
- Rory RuskovichHonolulu$5K
- Nicole EvansHonolulu$5K
- Ayanna JoseHonolulu$4K
- Christopher AcreeHonolulu$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.